Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Oktober 2015 09:30 ET | Quelle: Curetis AG

Curetis Announces New Supervisory Board of Curetis N.V.

AMSTERDAM, The Netherlands and HOLZGERLINGEN, Germany, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Curetis B.V.1 ("Curetis"), a developer of next-level molecular diagnostic solutions, today announced the...
05. Oktober 2015 11:00 ET | Quelle: Curetis AG

Curetis and Acumen to Collaborate on Unyvero Sepsis Test and ASEAN Distribution

Curetis licenses Acumen's proprietary sepsis biomarker panel for use with Unyvero Platform Diagnostics Development (DxD) Hub in Singapore to support Acumen in development and clinical...
25. September 2015 09:30 ET | Quelle: Curetis AG

Curetis Enters Into Distribution Agreement to Expand Commercial Activities Into Greater China

Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong Kong and Taiwan Clinical trials for CFDA regulatory approval in...
08. Juli 2015 10:39 ET | Quelle: Curetis AG

Curetis Initiates Next Phase of Unyvero U.S. FDA Trial in Lower Respiratory Tract Infections

First patient enrolled in prospective arm of IVD trial Study to include a total of at least 2,500 patient samples Milestone triggers payment of EUR 6.8 million financing...
24. Juni 2015 09:56 ET | Quelle: Curetis AG

Curetis' Unyvero System Selected for Global Phase III Antibiotics Trial

HOLZGERLINGEN, Germany, June 24, 2015 (GLOBE NEWSWIRE) -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced that Curetis' Unyvero System will be used in a Phase III...
11. Mai 2015 09:30 ET | Quelle: Curetis AG

Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer

HOLZGERLINGEN, Germany, May 11, 2015 (GLOBE NEWSWIRE) -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced Dr. Achim Plum has been appointed to the newly-created...
20. April 2015 09:30 ET | Quelle: Curetis AG

Curetis Expands Commercial Organization

Augmented direct sales force, led by new Head of International Sales, to broaden reach in key European markets New distribution partnerships in Italy and Middle East HOLZGERLINGEN, Germany,...
16. April 2015 09:30 ET | Quelle: Curetis AG

Curetis to Launch Next-Generation Pneumonia Application at ECCMID 2015

- Company Successfully Completes Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application - Clinical sensitivity across 40-marker panel averages 94% at 99.4% specificity...